Search for other papers by Melody Lok-Yi Chan in
Google Scholar
PubMed
Search for other papers by Sammy Wing-Ming Shiu in
Google Scholar
PubMed
Search for other papers by Ching-Lung Cheung in
Google Scholar
PubMed
Search for other papers by Anskar Yu-Hung Leung in
Google Scholar
PubMed
Search for other papers by Kathryn Choon-Beng Tan in
Google Scholar
PubMed
increases the expression of genes that promote cholesterol efflux ( 9 ). In addition to regulation by LXR, it has recently been suggested that statins may potentially influence IDOL expression in vitro ( 10 ). Statins are most widely used in lipid
Search for other papers by Ying-Lien Cheng in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for other papers by Ting-I Lee in
Google Scholar
PubMed
Search for other papers by Yu-Mei Chien in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for other papers by Ting-Wei Lee in
Google Scholar
PubMed
Cardiovascular Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan
Search for other papers by Yi-Jen Chen in
Google Scholar
PubMed
)D measurement, and had two 25(OH)D measurements less than 3 months or greater than 3 years apart ( Fig. 1 ). We collected data regarding patient characteristics, such as age, sex, body weight, body height, drug history (e.g., statin, fibric acids, nicotinic acid
Search for other papers by Eng-Loon Tng in
Google Scholar
PubMed
Search for other papers by Yee Sian Tiong in
Google Scholar
PubMed
Search for other papers by Aye Thida Aung in
Google Scholar
PubMed
Search for other papers by Nicole Ya Yuan Chong in
Google Scholar
PubMed
Search for other papers by Zhemin Wang in
Google Scholar
PubMed
-BLED score was not stated.Baseline characteristics of TAF and non-thyroid AF patients were compared. There were statistically significant differences in ACEI/ARB, beta blocker, digoxin, and statin use between groups. IS, mortality, major bleeding